Xinyaqiang Silicon Chemistry Co.,Ltd
SSE:603155.SS
13.02 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 720.54 | 675.204 | 1,133.599 | 879.996 | 490.329 | 601.952 | 650.019 | 267.404 | 191.964 | 169.526 | 179.909 | 211.811 |
| Cost of Revenue
| 571.147 | 510.053 | 785.393 | 502.214 | 288.009 | 303.998 | 343.881 | 155.493 | 120.697 | 115.111 | 108.413 | 170.062 |
| Gross Profit
| 149.393 | 165.151 | 348.206 | 377.782 | 202.32 | 297.954 | 306.139 | 111.911 | 71.267 | 54.415 | 71.496 | 41.749 |
| Gross Profit Ratio
| 0.207 | 0.245 | 0.307 | 0.429 | 0.413 | 0.495 | 0.471 | 0.419 | 0.371 | 0.321 | 0.397 | 0.197 |
| Reseach & Development Expenses
| 33.786 | 33.399 | 36.856 | 28.159 | 18.032 | 25.118 | 20.041 | 9.184 | 16.072 | 7.629 | 7.501 | 8.711 |
| General & Administrative Expenses
| 3.199 | 3.731 | 2.722 | 4.079 | 5.354 | 5.555 | 25.237 | 3.754 | -7.136 | 18.548 | 2.508 | 3.166 |
| Selling & Marketing Expenses
| 0.57 | 1.458 | 3.429 | 2.643 | 2.276 | 9.084 | 7.524 | 6.599 | 6.069 | 4.83 | 4.19 | 3.278 |
| SG&A
| 3.77 | 5.189 | 6.151 | 6.723 | 7.629 | 14.639 | 32.761 | 10.352 | -1.067 | 17.054 | 6.698 | 6.444 |
| Other Expenses
| -17.813 | -12.287 | 21.68 | 18.517 | 18.101 | 17.452 | 1.013 | 1.812 | 3.628 | 0 | 3.946 | 1.141 |
| Operating Expenses
| 19.742 | 26.301 | 64.687 | 53.399 | 43.763 | 57.208 | 67.472 | 27.618 | 25.355 | 16.728 | 21.868 | 20.744 |
| Operating Income
| 129.651 | 138.849 | 346.348 | 366.793 | 173.785 | 251.712 | 248.711 | 75.667 | 37.769 | 35.333 | 43.71 | 10.12 |
| Operating Income Ratio
| 0.18 | 0.206 | 0.306 | 0.417 | 0.354 | 0.418 | 0.383 | 0.283 | 0.197 | 0.208 | 0.243 | 0.048 |
| Total Other Income Expenses Net
| 1.167 | 2.446 | 61.365 | 2.561 | 9.131 | 12.6 | 1.013 | -2.618 | 3.628 | -0.993 | 3.946 | -5.802 |
| Income Before Tax
| 130.817 | 141.295 | 346.403 | 369.354 | 182.916 | 252.483 | 249.724 | 77.479 | 41.396 | 34.34 | 47.656 | 11.261 |
| Income Before Tax Ratio
| 0.182 | 0.209 | 0.306 | 0.42 | 0.373 | 0.419 | 0.384 | 0.29 | 0.216 | 0.203 | 0.265 | 0.053 |
| Income Tax Expense
| 16.677 | 18.197 | 44.768 | 49.909 | 25.58 | 33.063 | 38.575 | 11.246 | 5.93 | 5.019 | 5.115 | 1.651 |
| Net Income
| 114.361 | 123.44 | 301.717 | 319.445 | 157.336 | 219.42 | 211.15 | 66.233 | 35.467 | 29.321 | 42.541 | 9.61 |
| Net Income Ratio
| 0.159 | 0.183 | 0.266 | 0.363 | 0.321 | 0.365 | 0.325 | 0.248 | 0.185 | 0.173 | 0.236 | 0.045 |
| EPS
| 0 | 0.39 | 1.34 | 1.42 | 0.7 | 0.97 | 1.34 | 0.42 | 0.23 | 0.19 | 0.4 | 0.076 |
| EPS Diluted
| 0 | 0.39 | 1.34 | 1.42 | 0.7 | 0.97 | 1.34 | 0.42 | 0.23 | 0.19 | 0.4 | 0.076 |
| EBITDA
| 179.494 | 189.148 | 385.007 | 394.183 | 206.728 | 274.926 | 266.706 | 94.177 | 55.751 | 47.626 | 61.474 | 22.241 |
| EBITDA Ratio
| 0.249 | 0.28 | 0.34 | 0.448 | 0.422 | 0.457 | 0.41 | 0.352 | 0.29 | 0.281 | 0.342 | 0.105 |